Article
HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype.
Journal for immunotherapy of cancer - 13 Jun 2024
Luo Fan, Cao Jiaxin, Chen Qun, Liu Lusha, Yang Ting, Bai Xue, Ma Wenjuan, Lin Chaozhuo, Zhou Ting, Zhan Jianhua, Huang Yan, Yang Yunpeng, Zhao Hongyun, Zhang Li
Abstract excerpt
BACKGROUND: The sustained effectiveness of anti-programmed cell death protein-1/programmed death-ligand 1 treatment is limited to a subgroup of patients with advanced nasopharyngeal carcinoma (NPC), and the specific biomarker determining the response to immunotherapy in NPC remains uncertain. METHODS: We assessed the associations between pre-immunotherapy and post-immunotherapy serum lipoproteins and survival in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
